These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27114609)

  • 1. Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells.
    Getahun A; Beavers NA; Larson SR; Shlomchik MJ; Cambier JC
    J Exp Med; 2016 May; 213(5):751-69. PubMed ID: 27114609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens.
    Akerlund J; Getahun A; Cambier JC
    J Autoimmun; 2015 Aug; 62():45-54. PubMed ID: 26152931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.
    O'Neill SK; Getahun A; Gauld SB; Merrell KT; Tamir I; Smith MJ; Dal Porto JM; Li QZ; Cambier JC
    Immunity; 2011 Nov; 35(5):746-56. PubMed ID: 22078222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity.
    Szodoray P; Stanford SM; Molberg Ø; Munthe LA; Bottini N; Nakken B
    J Allergy Clin Immunol; 2016 Sep; 138(3):839-851.e8. PubMed ID: 27056269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
    Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC
    Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling mutations and autoimmunity.
    Yu CC; Mamchak AA; DeFranco AL
    Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putting on the Brakes: Regulatory Kinases and Phosphatases Maintaining B Cell Anergy.
    Franks SE; Cambier JC
    Front Immunol; 2018; 9():665. PubMed ID: 29681901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.
    Franks SE; Getahun A; Cambier JC
    J Immunol; 2019 Jun; 202(12):3381-3393. PubMed ID: 31076529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell receptor signaling in human systemic lupus erythematosus.
    Pugh-Bernard AE; Cambier JC
    Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.
    Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S
    J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHIP-1 Deficiency in AID
    Chen Y; Hu F; Dong X; Zhao M; Wang J; Sun X; Kim TJ; Li Z; Liu W
    J Immunol; 2017 Nov; 199(9):3063-3073. PubMed ID: 28972092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling.
    Gauld SB; Benschop RJ; Merrell KT; Cambier JC
    Nat Immunol; 2005 Nov; 6(11):1160-7. PubMed ID: 16200069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting Edge: Deletion of Ezrin in B Cells of Lyn-Deficient Mice Downregulates Lupus Pathology.
    Pore D; Huang E; Dejanovic D; Parameswaran N; Cheung MB; Gupta N
    J Immunol; 2018 Sep; 201(5):1353-1358. PubMed ID: 30021765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development.
    Tsantikos E; Maxwell MJ; Kountouri N; Harder KW; Tarlinton DM; Hibbs ML
    J Immunol; 2012 Aug; 189(4):1726-36. PubMed ID: 22798664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dok-3/Grb2 adaptor module promotes inducible association of the lipid phosphatase SHIP with the BCR in a coreceptor-independent manner.
    Manno B; Oellerich T; Schnyder T; Corso J; Lösing M; Neumann K; Urlaub H; Batista FD; Engelke M; Wienands J
    Eur J Immunol; 2016 Nov; 46(11):2520-2530. PubMed ID: 27550373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FcγRIIB-Independent Mechanisms Controlling Membrane Localization of the Inhibitory Phosphatase SHIP in Human B Cells.
    Pauls SD; Ray A; Hou S; Vaughan AT; Cragg MS; Marshall AJ
    J Immunol; 2016 Sep; 197(5):1587-96. PubMed ID: 27456487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
    Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
    Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Src-family kinase Lyn plays a critical role in establishing and maintaining B cell anergy by suppressing PI3K-dependent signaling.
    Fiske BE; Wemlinger SM; Crute BW; Getahun A
    bioRxiv; 2024 May; ():. PubMed ID: 38826354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy.
    Browne CD; Del Nagro CJ; Cato MH; Dengler HS; Rickert RC
    Immunity; 2009 Nov; 31(5):749-60. PubMed ID: 19896393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.
    Sattler M; Salgia R; Shrikhande G; Verma S; Choi JL; Rohrschneider LR; Griffin JD
    Oncogene; 1997 Nov; 15(19):2379-84. PubMed ID: 9393882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.